Bang Surgical Successfully Moves Low Cost OR Product Support System Into Cardiac Surgery
Thursday Oct 13 2011
San Antonio – October 13, 2011: St Lukes Hospital In San Antonio Texas Performs First US Cardiac Surgery Using Bang Surgical

Dr. Carmelo Otero was the first US Cardiothoracic Surgeon to use Bang Surgical’s mobile OR product support system during one of his cardiac surgery cases. Bang Surgical offers an OR grade low cost product support solution that allows experts from all over the world to communicate live during surgery.

Dr. Otero is a leader in minimally invasive robotic assisted surgery and has to travel in order to train others in cardiac surgery. Bang Surgical allows Dr. Otero to use his expertise to train others without the high cost of travel and time. Dr. Otero is one of the few Cardiac Surgeons in the US that has knowledge and training in performing minimally invasive procedures percutaneously. That means he can perform procedures on a patient’s heart through only a small incision in the patients leg or arm alongside Cardiologists. Dr. Otero is leading the way to establish teams of Cardiologists and Cardiac Surgeons to offer patients the highest level of patient care using state of the art technologies and surgical techniques. Dr Otero is also on the forefront of offering his medical expertise in remote areas where there are not established medical centers.

St. Luke’s Baptist Hospital and Dr. Carmelo Otero were the first health system in San Antonio and south Texas to offer patients minimally invasive surgery using the da Vinci® Surgical System. Ted Schwartz, CEO of Bang Surgical, states, “Bang Surgical allows medical device experts from anywhere around the world, to interact during surgery allowing medical device companies’ representatives, clinical experts, and engineers to provide support of their products during surgery. This is a first in cardiac surgery with huge opportunities for hospitals to improve patient care and reduce costs.” Bang Surgical is committed to improving communications amongst medical device companies and hospitals in order to reduce healthcare costs yet improve patient outcomes.